Post Number: 1384
|Posted on Thursday, April 08, 2021 - 11:04 am: |
When the Biden administration came in, they took a new look at this,” Merck CEO Ken Frazier said. “It’s not a black-or-white situation. We were inclined to do something. They made it more possible for it to happen in a tiThese dynamics cast the early rollout in a new light.
“For me, the first big test was going to be how well they did with the J & J distribution, which was totally their thing and not left over from the prior administration,” said Walid Gellad, a pharmaceutical expert at the University of Pittsburgh, referring to the single-shot doses that were first authorized under the Biden administration last month.
Of the 3.9 million Johnson & Johnson doses that began shipping out at the beginning of last week, about 630,000 had been administered as of Thursday, according to Centers for Disease Control and Prevention data.